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Abstract Different groups of biosurfactants exhibit
diverse properties and display a variety of physiological
functions in producer microorganisms; these include
enhancing the solubility of hydrophobic/water-insoluble
compound, heave metal binding, bacterial pathogenesis, cell
adhesion and aggregation, quorum sensing and biofilm for-
mation. Candida sphaerica was grown in a low cost med-
ium, consisting of distilled water supplemented with 9%
refinery residue of soybean oil and 9% corn steep liquor, for
144 h at 28C and 150 rpm. The cell-free supernatant
obtained at the end of the experiments was submitted to
extraction, and afterward the biosurfactant was isolated
using methanol with a yield of 9 g l-1. The critical micelle
concentration of the biosurfactant was found to be
0.25 mg ml-1 with a surface tension of 25 mN m-1. Several
concentrations of the biosurfactant (0.625–10 mg ml-1)
were used to evaluate its antimicrobial and antiadhesive
activities against a variety of microorganisms. The biosur-
factant showed antimicrobial activity against Streptococcus
oralis (68%), Candida albicans (57%), and Staphylococcus
epidermidis(57.6%) for the highest concentration tested.
Furthermore, the biosurfactant at a concentration of
10 mg ml-1 inhibited the adhesion between 80 and 92% of
Pseudomonas aeruginosa, Streptococcus agalactiae,
Streptococcus sanguis12. Inhibition of adhesion with per-
centages near 100% occurred for the higher concentrations
of biosurfactant used. Results gathered in this study point to a
potential use of the biosurfactant in biomedical applications.
Introduction
Several compounds with tensoativos properties are syn-
thesized by living organisms, from plants (e.g., saponins)
to microorganisms (e.g., glycolipids) and humans (e.g.,
pulmonary surfactant), being considered natural surfactants
[5, 31]. In addition, these compounds have been produced
through biotechnological processes broadening their
diversity and potential applications [27]. Surfactants are
usually organic compounds that are amphiphilic, meaning
they contain both hydrophobic groups (‘‘tails’’) and
hydrophilic groups (‘‘heads’’), and that act preferably in the
interface of fluid phases with different levels of polarity
and bridges of hydrogen, such as oil/water or air/water
interfaces. Many microbes appear to produce a complex
mixture of biosurfactants, particularly during their growth
on water-immiscible substrates. In general, biosurfactants
are microbial metabolites with the typical amphiphilic
structure of a surfactant, where the hydrophobic moiety
is either a long-chain fatty acid, hydroxyl fatty acid, or
a-alkyl-b-hydroxy fatty acid and the hydrophilic moiety
can be a carbohydrate, an amino acid, a cyclic peptide, a
phosphate, a carboxylic acid, or alcohol, among others
[26]. Physical and chemical properties, surface tension
reduction, and stability of the emulsion formed are
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important characteristics in a biosurfactant that make
possible its use in countless biological applications. Most
work on biosurfactant applications has been focused on
their use in environmental applications owing to their
diversity, environmentally friendly nature, suitability for
large-scale production and selectivity [6]. Biosurfactants
have several advantages over chemical surfactants, such as
lower toxicity, higher biodegradability, and effectiveness at
extreme temperatures or pH values [9, 30]. Many of the
potential applications that have been considered for bio-
surfactants depend on whether they can be produced eco-
nomically; however, much effort in process optimization
and at the engineering and biological levels has been car-
ried out [34]. Despite their potential and biological origin
only a few studies have been carried out on applications
related to the biomedical field [4]. Some biosurfactants are
suitable alternatives to synthetic medicines and antimi-
crobial agents and may be used as safe and effective
therapeutic agents [28, 46].
Furthermore, biosurfactants have been found to inhibit
the adhesion of pathogenic organisms to solid surfaces or
to infection sites hampering biofilm formation that is the
cause of many diseases, as for example cystic fibrosis [2,
12, 35]. Therefore, prior adhesion of biosurfactants to solid
surfaces might constitute a new and effective means of
combating colonization by pathogenic microorganisms and
subsequent biofilm formation [14, 38, 40, 41, 46].
Pre-coating vinyl urethral catheters by running a surf-
actin solution through them before inoculation with media
resulted in a decrease in the amount of biofilm formed by
Salmonella typhimurium, Salmonella enterica, Escherichia
coli, and Proteus mirabilis [29]. Given the importance of
opportunistic infections with Salmonella species, including
urinary tract infections of AIDS patients, these results have
great potential for practical applications. In addition, the
use of lactobacilli as a probiotic for the prevention of
urogenital infections has been widely studied [7].
The aim of this study was to isolate and characterize the
medical main functional properties of the crude biosurfac-
tant produced by Candida sphaerica. Characterization
included the determination of the surface tension and critical
micelle concentration. The antimicrobial and antiadhesive
activities of this biosurfactant were assayed against a group
of pathogenic and non-pathogenic microorganisms.
Materials and Methods
Microorganisms and Culture Conditions
Candida sphaerica UCP0995, isolated from soil contami-
nated with metal and obtained from the culture collection
of the Universidade Cato´lica de Pernambuco (Brazil), was
used for the production of the biosurfactant Lunasan. The
microrganism was maintained at 5C on Yeast Mold Agar
(YMA) (OXOID, Basingstoke, England) slants containing
(w/v): yeast extract (0.3%), malt extract (0.3%), tryptone
(0.5%), D-glucose (1.0%), and agar (5.0%). Transfers were
conducted to fresh agar slants each month to maintain
viability.
Several strains that commonly colonize prostheses and
medical devices were used to test the antimicrobial and
antiadhesive properties of the biosurfactant. Lactobacillus
casei 36, Lact. casei 72, Lactobacillus reuteri 104R, and
Lact. reuteri ML1 were cultured in De Man, Rogosa, and
Sharpe (MRS broth) slants containing (w/v): peptone (1%),
meat extract (0.8%), yeast extract (0.4%), glucose (2%),
sodium acetato trihydrate (0.5%), polysorbate 80 (0.1%),
dipotassium hydrogen phosphate (0.2%), magnesium sul-
fate heptahydrate (0.02%), manganese sulfate heptahydrate
(0.05%), and agar (1.0%). Streptococcus mutans NS,
Strept. mutans HG985, Streptococcus oralis J22, and
Streptococcus sanguis 12 were cultured in Todd Hewitt
Broth (THB) slants containing (w/v): heat infusion (0.3%),
peptone (2.0%), dextrose (0.2%), sodium bicarbonate
(0.2%), sodium chloride (0.2%), and disodium phos-
phate (0.04%). P. aeruginosa, Staphylococcus aureus,
Staphylococcus epidermidis, Streptococcus agalactiae and,
Streptococcus pyogenes were cultured in Trypticase Soy
Broth (TSB) (OXOID, Basingstoke, England) slants con-
taining (w/v): tryptose (2.0%), dextrose (0.1%), disodium
phosphate (0.2%), potassium nitrate (0.1%), and agar
(1.0%). Candida albicans was grown in Yeast Mold Agar
(YMA) All the strains were grown at 37C, with the
exception of C. albicans (31C). All media were obtained
from Oxoid. Strains were stored at -80C in the appro-
priate medium containing 15% (v/v) glycerol solution until
they were used. Whenever required, frozen stocks were
streaked on agar plates and incubated overnight at the
optimum growing temperature for each strain for further
culturing. Working stock cultures were kept at 4C for up
to 2 weeks [20].
Growth Conditions
The inoculum of C. sphaerica was prepared by transferring
cells grown on a slant to 50 ml of Yeast Mold broth
(YMB). The seed culture was incubated for 24 h at 28C C
and agitated at 150 rpm. The yeast was cultivated in sub-
merged culture with shaking in a New Bruswick C-24
shaker. The production of the Lunasan biosurfactant was
performed in distilled water-based medium with 9% of
refinery residue of soybean oil and 9% of corn steep liquor.
The medium was sterilized by autoclaving at 121C for
20 min. The final pH of the medium was 5.3 and the sur-
face tension before inoculation was 50 mN m-1. The
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inoculum (1% v/v) was introduced in the amount of
104 cells ml-1 to cool medium yeast. Cultivation was
carried out in Erlenmeyer flasks at 27C with shaking at
150 rpm for 144 h. At regular intervals, samples were
withdrawn for analyses. All the assays were carried out in
triplicate and did not vary more than 5%.
Isolation of Biosurfactant
After 144 h cultivation of C. sphaerica in the above-
described conditions, the cell-free supernatant (9% of
refinery residue of soybean oil and 9% of corn steep liquor)
was submitted to an extraction process. The pH was
adjusted to 2 with HCl 6 M and precipitated with two
volumes of methanol. After resting for 24 h at 4C, sam-
ples were centrifuged at 50009g for 30 min, washed twice
with cold methanol, and dried in an incubator at 37C for
24–48 h, until constant weight. Afterward, the samples
were kept in desiccators to reach the current weight and the
biosurfactant yield (g l-1) was determined. Known
amounts of crude precipitate were resuspended in distilled
water and used for measurement of the critical micelle
concentration (CMC). All experiments were conducted in
triplicate.
Determination of Superficial Tension and Critical
Micelle Concentration (CMC)
The surface tension was measured by the ring method
using a DuNouy Tensiometer model Sigma 70 (KSV
Instruments LTD, Finland) at room temperature. The
concentration at which micelles began to form was repre-
sented as the CMC. The CMC was automatically deter-
mined by measuring the surface tensions of the purified
biosurfactant in distilled water up to a constant value of
surface tension [24].
Determination of Antimicrobial Activity
of Biosurfactant
The antimicrobial activity of the crude biosurfactant
against several microbial strains was determined by the
microdilution method [36, 39] in 96-well flat-bottom
plastic tissue culture plates (Greiner Bio-One GmbH,
Frickenhausen, Germany). For each strain, appropriate
medium and temperature were used (as previously descri-
bed); briefly, 125 ll of sterile, double-strength culture
medium were placed into the first column of the 96-well
microplate and 125 ll of sterile, single-strength culture
medium in the remaining wells. Subsequently, 125 ll of
biosurfactant solution (concentrations from 0.625 to
10 mg ml-1) in PBS—phosphate- buffered (100 mg ml-1)
were added to the first column of the microplate and mixed
with the medium; this results in a biosurfactant concen-
tration of 50 mg ml-1 serially, 125 ll were transferred to
the subsequent wells, discarding 125 ll of the mixture in
the tenth column, so that the final volume for each well
was 125 ll. This process results in twofold serial dilu-
tions of the biosurfactant in the first 10 columns
(10–0.625 mg ml-1). Columns 11 and 12 did not contain
biosurfactant and served as negative and growth controls,
respectively. All the wells (except for the 11th column)
were inoculated with 25 ll of an overnight culture at the
defined optimum conditions, diluted to 108 CFU ml-1).
Microplates were covered and incubated for 48 h under the
appropriate growth conditions for each microorganism.
Triplicate assays were performed at all the biosurfactant
concentrations for each strain. After 48 h of incubation, the
absorbance at 600 nm (A600) was determined for each
well. The growth inhibition percentages at different bio-
surfactant concentrations for each microorganism were
calculated as:
% Growth inhibitionc ¼ 1  Ac=A0ð Þ½   100
where Ac represents the absorbance of the well with a
biosurfactant concentration c and A0 the absorbance of the
control well (without biosurfactant) [19].
Determination of Antiadhesion of Biosurfactant
The antiadhesive activity of the crude biosurfactant iso-
lated from Candida sphaerica against several microbial
strains was quantified according to the procedure described
by Heinemann et al. [21]. Briefly, the wells of a sterile 96-
well flat-bottomed plastic tissue culture plate (Greiner Bio-
One GmbH) were filled with 200 ll of the crude biosur-
factant. Several biosurfactant concentrations that were
tested ranging from 0.625 to 10 mg ml-1 plate were
incubated for 18 h at 4C and subsequently washed twice
with PBS. Control wells contained PBS buffer only. An
aliquot of 200 of a washed bacterial or yeast suspension
(108 CFU ml-1) was added and incubated in the wells for
4 h at 4C. Unattached microorganisms were removed by
washing the wells three times with PBS. The adherent
microorganisms were fixed with 200 ll of methanol (99%
purity) per well, and after 15 min, the plates were emptied
and left to dry. Then the plates were stained for 5 min with
200 ll of 2% crystal violet used for Gram staining per well.
Excess stain was rinsed out by placing the plate under
running tap water. Subsequently, the plates were air-dried,
the dye bound to the adherent microorganisms was reso-
lubilized with 200 ll of 33% (v/v) glacial acetic acid per
well, and the absorbance of each well was measured at
595 nm. The microbial inhibition percentages at different
biosurfactant concentrations for each microorganism were
calculated as:
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% Microbial inhibitionc ¼ 1  Ac=A0ð Þ½   100
where Ac represents the absorbance of the well with a
biosurfactant concentration c and A0 the absorbance of the
control well. The microtitre-plate antiadhesion assay esti-
mates the percentage of microbial adhesion reduction in
relation to the control wells, which were set at 0% to
indicate the absence of biosurfactant and therefore of its
antiadhesion properties. In contrast, negative percentage
results indicate the percentage increase in microbial
adhesion at a given surfactant concentration in relation to
the control. The microtitre-plate antiadhesion assay allows
the estimation of the crude biosurfactant concentrations
that are effective in decreasing adhesion of the microor-
ganisms studied [20].
Results and Discussion
The yield of the biosurfactant produced by C. sphaerica
was 9 g l-1 after 144 h of experiment, which is in accor-
dance with the values previously reported in the literature
[26]. Sarubbo et al. [43] reported a yield of 8 g l-1 for a
biosurfactant produced by C. lipolytica using canola oil and
glucose as substrates. Also, Rufino et al. [42] obtained a
yield of 8 g l-1 for the biosurfactant from C. lipolytica
using yeast extract and soybean oil refinery residue is
substrates. Furthermore, studies conducted by Sobrinho
et al. [47] using two industrial refinery residue of soybean
oil and corn steep liquor as carbon sources indicated a yield
of 4.5 g l-1 of biosurfactant produced by C. sphaerica.
An important property of a biosurfactant is its ability to
act in the formation of micelles which are aggregates of
amphipathic molecules [3, 22]. Surface tension decreases
as the surfactant concentration in an aqueous medium
increases and micelles are formed. The critical micelle
concentration (CMC) is the minimum biosurfactant con-
centration necessary to reduce the surface tension to the
maximum extent. The biosurfactant from C. sphaerica
showed a great surface tension reduction capacity since the
water surface tension was reduced from 70 to 25 mN m-1
with the increase of the biosurfactant concentration up to
CMC of 0.25 mg ml-1 (Fig. 1). From this point the
increase of biosurfactant concentration did not lead to
further reductions in water surface tension, indicating that
the CMC had been reached. Results show that the biosur-
factant produced by C. sphaerica possesses an increased
capacity to reduce tension as compared to the biosurfac-
tants from C. lipolytica (32 mN m-1) [42], C. glabrata
(31 mN m-1) [44], C. antarctica (35 mN m-1) [1], and
Yarrowia lipolytica (50 mN m-1) [18]. Furthermore, the
biosurfactant produced in this study also showed a CMC
that is much lower than the CMCs reported for other yeast
surfactants, considering the rates of 2.5% for C. glabrata
[27] biosurfactants, 1% for C. lipolytica biosurfactant
grown in refinery waste [41], and 0.8 mg ml-1 for
C. sphaerica [47].
The antimicrobial activity of the biosurfactant isolated
from Candida sphaerica was determined by measuring the
growth inhibition percentages obtained for several micro-
organisms (Table 1). The tested biosurfactant presented
antimicrobial activity against all microorganisms used,
although, depending on the microorganism, the biosurfac-
tant presents different effective concentrations. The highest
concentration of biosurfactant tested (10 mg ml-1) showed
high percentages of inhibition for Streptococcus oralis J22
(68%), C. albicans (57%), and Staphylococcus epidermidis
(57.6%). The antimicrobial activity of the crude biosur-
factant isolated from Candida sphaerica with concentra-
tions between 5 and 10 mg ml-1 against C. albicans,
Staph. aureus and Staph. epidermidis was less to that
obtained with the biosurfactants isolated from Lact. para-
casei ssp A20, which completely inhibited the growth of
those microorganisms with concentrations between 25 and
50 mg ml-1) [20]. The crude biosurfactant showed anti-
microbial activity against a broad range of microorganisms,
including Gram-positive and Gram-negative bacteria and
yeasts. Biosurfactants antimicrobial activity has been
described, as for example surfactin, a cyclic lipopeptide
produced by Bacillus subtilis [32]. The antimicrobial
activity of surfactin was tested against several microbes.
All tested bacteria, except for B. subtilis, showed suscep-
tibility to surfactin. P. aeruginosa was the most sensitive
Gram-negative bacteria, while E. coli, Salmonella choter-
asius, and Serratia marcescens were inhibited in a lower
level. Also, the lipopeptide affected the growth of Gram-
positive bacteria, especially Micrococcus luteus and
Bacillus cereus [35]. Other examples have been reported
by Rodrigues et al. [35, 37, 38]. Crude biosurfactants
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Fig. 1 Surface tension versus concentration of isolated biosurfactant
produced by Candida sphaerica grow in distilled water supplemented
with 9.0% of refinery residue of soybean oil and 9% corn steep liquor
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isolated from Lactococcus lactis 53 and Streptococcus
thermophilus A showed antimicrobial activity against
C. troplicalis GB in low concentrations. Some biosurfac-
tants are able, even in low concentrations, to destabilize the
microorganisms membranes, killing them or disabling their
growth [10, 11]. The interest in biosurfactants was first
expressed due to its potential antimicrobial properties,
being the first reported and actually the most studied bio-
surfactants, rhamnolipid, and surfactin [45]. Gram-positive
bacteria are more sensitive to biosurfactants than Gram-
negative bacteria, which are weakly inhibited or not
inhibited at all [15]. C. bombicola and C. apicola were
reported to produce a glycolipid-type biosurfactant (soph-
orolipid) that inhibit the growth of B. subtilis, S. epide-
rmidis, and Streptococcus faecium in concentrations
between 6 and 29 mg l-1 [25]. Other glycolipids inhibit
not only the growth of Gram-positive bacteria, but also
Gram-negative ones, such as E. coli and S. marcescens
[46]. Kitamoto et al. [23] reported in their study an anti-
microbial activity against S. aureus, E. coli, P. aeruginosa,
and C. albicans for a mannosylerythritol produced by
C. antarctica, a sophorolipid produced by C. apicola, and a
rhamnolipid produced by P. aeruginosa. Several biosur-
factants that exhibit antimicrobial activity have been pre-
viously described. However, there are few reports about the
antimicrobial activity of biosurfactants isolated from
Candida; only biosurfactants obtained from S. thermophi-
lus A and L. lactis 53 showed significant antimicrobial
activity against several bacterial and yeast strains isolated
from explanted voice prostheses [25].
Adhesion to surfaces and subsequent biofilm formation
consist in a surviving strategy used by microorganisms in
several hostile environments, protecting them from dehy-
dration, predators, biocides and extreme conditions [13].
The antiadhesive activity of this biosurfactant was evalu-
ated against a variety of bacterial and fungal strains. The
biosurfactant showed antiadhesive activity against most of
the microorganisms tested, but the antiadhesive effect
depends on the concentration and the microorganism tested
(Table 2).This biosurfactant was effective against all the
microorganisms tested, albeit to different degree. With
regard to the Lactobacillus strains, the antiadhesive activity
was higher against Lact. casei (90%), Lact. casei 72 (72%),
Lact. reuteri 104R (55%) and Lact. reuteri ML1 (40%).
The pathogenic bacteria studied (Streptococcus agalactiae,
Staphylococus epidermidis, Staphylococus aureus) a com-
plete inhibition of adhesion was also achieved with bio-
surfactant concentrations of 10 mg ml-1. Regarding the
yeast, a total inhibition of adhesion was also observed for
C. albicans at a biosurfactant concentration of 10 mg ml-1.
The highest percentages of adhesion inhibition were
obtained for P. aeruginosa (100%), Staphylococcus aureus
(100%), Streptococcus oralis J22 (97%), while low activity
was obtained for Streptococcus mutans HG 985(50%)
and Staphylococcus epidermidis GB (22%). The antiadhe-
sive activity of the crude biosurfactant isolated from
Table 1 Percentages of growth inhibition obtained with the crude biosurfactant isolated from Candida sphaerica at different concentrations
(mg ml-1)
Microorganism Biosurfactant (mg ml-1)
0.625 1.25 2.5 5 10
Lactobacillus casei 5.5 ± 0.2 12 ± 0.3 15 ± 0.1 30 ± 0.4 40.4 ± 0.2
Lactobacillus casei 72 5.5 ± 0.3 11 ± 0.2 13 ± 0.4 25 ± 0.3 43.3 ± 0.1
Lactobacillus reuteri 104R 10 ± 0.1 17.3 ± 0.3 22 ± 0.5 4.4 ± 0.3 46.5 ± 0.1
Lactobacillus reuteri ML1 8.5 ± 0.3 11 ± 0.2 16 ± 0.2 27 ± 0.2 49 ± 0.2
Streptococcus agalactiaea 7.3± 0.2 10 ± 0.3 11± 0.3 35 ± 0.2 46 ± 0.2
Streptococcus mutans 14 ± 0.1 17.8 ± 0.1 22.6 ± 0.1 38.3 ±0.1 40.2 ± 0.6
Streptococcus mutans NS 14.2 ± 0.3 15.6 ± 0.4 20 ± 0.3 23.8 ± 0.1 36 ± 0.1
Streptococcus mutans HG 22 ± 0.2 33.1 ± 0.1 45.6 ± 0.3 46± 0.4 48± 0.1
Streptococcus pyogenes 10.3 ± 0.6 15.4 ± 0.1 28 ± 0.1 32.2 ± 0.5 42.5 ± 0.2
Streptococcus sanguis 12 13.6± 0.3 15 ± 0.4 15.5 ± 0.5 28 ±0.8 39 ± 0.1
Streptococcus oralis J22 11 ± 0.4 13.2 ± 0.3 15.2 ± 0.3 30.7 ± 0.4 68 ± 0.2
Staphylococcus epidermidisa 8.3 ± 0.1 13.5 ± 0.2 25 ± 0.2 42± 0.1 57.6 ± 0.3
Staphylococcus aureusa 10.6± 0.1 20 ± 0.2 27.3 ± 0.3 32.2± 0.2 43.9± 0.1
Pseudomonas aeruginosa 7.7 ± 0.1 8.0 ± 0.1 12.5 ± 0.1 13.6 ±0.4 47 ± 0.2
Candida albicansa 12.5± 0.2 17.3 ± 0.3 32 ± 0.3 44.2 ± 0.1 57 ± 0.2
Results are expressed as means ± standard deviations of values obtained from triplicate experiments
a Pathogenic microorganisms
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C. sphaerica completely inhibited the adhesion with a
concentration of 10 mg ml-1 against Streptococcus aga-
lactiae, Streptococcus mutans, Streptococcus mutans NS,
Streptococcus sanguis 12, Streptococcus. These results
were higher to that obtained with the biosurfactants isolated
from Lact. paracasei ssp A20 [19]. A role of biosurfactants
as defense weapons in competition with post-adhesion has
been suggested for biosurfactants produced by Streptococcus
mitis and S. mutans [8]. Besides possessing antifungal,
antibacterial and antiviral activities, biosurfactants have also
proved to be great inhibitors of microbial adhesion and of
biofilm formation. For example, the biosurfactant released
by S. mitis was found to reduce the adhesion of Streptococ-
cus. mutans [33]. Similarly, Lactobacillus fermentum RC-14
releases surfactant compounds that can inhibit the adhesion
of uropathogenic bacteria, including Enterococcus faecalis.
The adsorption of a biosurfactant on surface was found to
change its hydrophobicity, which might caused interference
in the adhesion and desorption processes [17]. Furthermore,
Velraeds et al. [48] reported the inhibition of adhesion of
pathogenic enteric bacteria by a biosurfactant produced by
Lactobacillus fermetum RC-14. The authors suggested the
use of this antiadhesive agent in catheters aiming at
decreasing biofilm formation. Falagas and Makris [16] have
proposed the application of biosurfactants isolated from
probiotic bacteria to patient care equipments (such as cath-
eters and other medical insertional devices) in hospitals, with
the aim of decreasing colonization by microorganisms
responsible for nosocomial infections.
This study we have demonstrated the antimicrobial and
antiadhesive properties of the new biosurfactant isolated
from C. sphaerica against several pathogenic and non-
pathogenic microorganisms. The results obtained suggest
the possible use of this biosurfactant as an alternative
antimicrobial agent in the medical field for applications
against microorganisms responsible for diseases and
infections in the urinary, vaginal, and gastrointestinal
tracts, as well as in the skin, making it a suitable alternative
to conventional antibiotics. Furthermore, due to its anti-
adhesive activity, the biosurfactant can potentially be used
as a coating agent for several medical devices, an appli-
cation area not explored yet for biosurfactants obtained
from yeasts.
Acknowledgments The authors acknowledge the funding agencies
FACEPE, CNPq, FINEP, PRONEX, and UNICAMP for using their
facilities and CAPES for sandwich doctorate scholarship.
References
1. Adamczak M, Bednarski W (2000) Influence of medium com-
position and aeration on the synthesis of surfactants produced by
Candida Antarctica. Biotechnol Lett 22:313–316
2. Ahimou F, Jacques P, Deleu M (2001) Surfactin and iturin A
effects on Bacillus subtilis surface hydrophobicity. Enzym Mic-
rob Technol 27:749–754
3. Amaral PFF, Silva JM, Lehocky M, Barros-Timmons AMV,
Coelho MAS, Marrucho IM, Coutinho JAP (2006) Production
and characterization of a bioemulsifier from Yarrowia lipolytica.
Process Biochem 41:1894–1898
Table 2 Antiadhesive properties of crude biosurfactant isolated from Candida sphaerica
Microorganism Biosurfactant (mg ml-1)
0.625 1.25 2.5 5 10
Lactobacillus casei 53 ± 0.1 53 ± 0.2 56 ± 0.1 67 ± 0.3 90 ± 0.2
Lactobacillus casei 72 59 ± 0.3 61 ± 0.2 65 ± 0.4 70 ± 0.2 72 ± 0.1
Lactobacillus reuteri 104R 41 ± 0.1 42 ± 0.1 45 ± 0.4 50 ± 0.2 55 ± 0.1
Lactobacillus reuteri ML1 26 ± 0.2 28 ± 0.1 30 ± 0.3 34 ± 0.2 40± 0.2
Streptococcus agalactiaea 80± 0.1 86 ± 0.2 88± 0.2 92 ± 0.3 100 ± 0.2
Streptococcus mutans 58± 0.1 64 ± 0.1 67 ± 0.1 80 ±0.2 100± 0.1
Streptococcus mutans NS 60 ± 0.3 65 ± 0.2 68 ± 0.2 80 ± 0.3 100± 0.2
Streptococcus mutans HG 41 ± 0.2 42 ± 0.1 44± 0.2 47± 0.2 50± 0.1
Streptococcus pyogenes 33 ± 0.3 40 ± 0.1 42 ± 0.1 47± 0.5 49 ± 0.2
Streptococcus sanguis 12 80± 0.3 83 ± 0.4 87 ± 0.1 98 ±0.2 100± 0.1
Streptococcus oralis J22 77 ± 0.1 84 ± 0.1 88 ± 0.3 95 ± 0.4 97 ± 0.2
Staphylococcus epidermidisa 11 ± 0.1 12 ± 0.1 13 ± 0.2 19± 0.1 100± 0.3
Staphylococcus aureusa 75± 0.2 82± 0.3 85 ± 0.3 90± 0.2 100± 0.1
Pseudomonas aeruginosa 80 ± 0.2 82 ± 0.1 83± 0.3 89 ±0.2 92 ± 0.2
Candida albicansa 52± 0.3 56± 0.2 57 ± 0.1 64 ± 0.2 100 ± 0.2
Negative controls were set at 0% to indicate the absence of biosurfactant. Positive percentages indicate the reductions in microbial adhesion
when compared to the control
a Pathogenic microorganisms
J. Luna et al.: Evaluation Antimicrobial and Antiadhesive Properties
123
4. Benincasa M, Abalos A, Oliveira I, Manresa A (2004) Chemical
structure, surface properties and biological activities of the bio-
surfactant produced by Pseudomonas aeruginosa LB1 from
soapstock. Antonie Van Leeuwenhoek 85:1–8
5. Benincasa M (2007) Rhamnolipid produced from agroindustrial
wastes enhances hydrocarbon biodegradation in soil. Curr
Microbial 56:445–449
6. Banat IM, Makkar R, Cameotra S (2000) Potential commercial
applications of microbial surfactants. Appl Microbiol Biotechnol
53:495–508
7. Boris S, Barbe0s C (2000) Role played by lactobacilli in con-
trolling the population of vaginal pathogens. Microbes Infect
2:543–546
8. Busscher HJ, Van Hoogmoed CG, Geertsema-Doornbusch GI,
Van Der Kuijl-Booij M, Van Der Mei HC (1997) Streptococcus
thermophilus and its biosurfactants inhibit adhesion by Candida
spp. On silicone rubber. Appl Environ Microbiol 63:3810–3817
9. Cameotra S, Makkar R (1998) Synthesis of biosurfactants in
extreme conditions. Appl Microbiol Biotechnol 50:520–529
10. Calvo C, Manzanera M, Silva-Castro GA, Gonza´lez-Lope´z J
(2009) Application of bioemulsifiers in soil oil bioremediation
processes. Future prospects. Sci Total Environ 407:3634–3640
11. Carrilo C, Teruel JA, Aranda FJ, Ortiz A (2003) Molecular
mechanism of membrane permeabilization by the peptide anti-
biotic surfactin. Biochim Biophys Acta 1611:91–97
12. Das P, Mukherjee S, Sen R (2009) Antiadhesive action of a
marine microbial surfactant. Colloids Surf B Biointerfaces
71:183–186
13. Dunne Jr WM (2002) Bacterial adhesion: seen any good biofilms
lately. Clin Microbiol Rev 15:155–166
14. Elving GJ, Van Der Mei HC, Busscher HJ, Van Weissenbruch R,
Albers FW (2002) Comparison of the microbial composition of
voice prosthesis biofilms from patients requiring frequent versus
infrequent replacement. Ann Otol Rihinol Laryngol 111:200–203
15. Elving GJ, Van Der Mei HC, Busscher HJ, Amerogen EC, Van
Weissenbruch R, Albers FW (2000) Antimicrobial activity of
synthetic salivary peptides against voice prosthetic microorgan-
isms. Laryngoscope 110:321–324
16. Falagas MF, Makris GC (2009) Probiotic bacteria and biosur-
factants for nosocomial infection control: a hypothesis. J Hosp
Infect 71:301–306
17. Fischer W (1996) Molecular analysis of lipid macroamphiphiles
by hydrophobic interaction chromatography. J Microbiol Meth-
ods 25:129–144
18. Gallert C, Winter J (2002) Solid and liquid residues as raw
materials for biotechnology. Zeitschrift fur Naturforschung
89:483–496
19. Gudin˜a EJ, Rocha V, Teixeira JA, Rodrigues LR (2010) Anti-
microbial and antiadhesive properties of a biosurfactant isolated
from Lactobacillus paracasei ssp. paracasei A20. Appl Microbiol
50:419–424
20. Gudin˜a EJ, Teixeira JA, Rodrigues LR (2010) Isolation and
functional characterization of a biosurfactant produced by Lac-
tobacillus paracasei. Colloids Surf B Biointerfaces 76:298–304
21. Heinemann C, Hylckama V, Van Johan ET, Janssen DB,
Busscher HJ, Van Der Mei HC, Reid G (2000) Purification and
characterization of a surface-binding protein from Lactobacillus
fermentum RC-14 that inhibits adhesion of Enterococcus faecalis
1131. FEMS Microbiol Lett 90:177–180
22. Hua Z, Chen J, Lun S, Wang X (2003) Influence of biosurfactants
produced by on surface properties of microorganism and bio-
degradation of n-alkanes. Water Res 37:4143–4150
23. Kitamoto D, Isoda H, Nakahara T (2002) Functions and potential
applications of glycolipid biosurfactants—from energy-saving
materials to gene delivery carriers. J Biosci Bioeng 94:187–201
24. Kuyukina MS, Ivshina IB, Makarov SO, Litvinenko LV, Cunn-
ingham CJ, Philip JC (2005) Effect of biosurfactants on crude oil
desorption and mobilization in a soil system. Environ Int
31:155–161
25. Lang S, Katsiwela E, Wagner F (1989) Antimicrobial effects of
biosurfactants. Fat Sci Technol 9:363–366
26. Luna JM, Sarubbo LA, Campos-Takaki GM (2009) A new bio-
surfactant produced by Candida glabrata UCP1002: character-
istics of stability and application in oil recovery. Braz Arch Biol
Technol 52:785–793
27. Luna JM, Rufino RD, Sarubbo LA, Campos-Takaki GM (2008)
Produc¸a˜o de biossurfactante em meio de baixo custo formulado
com a´gua do mar. Exacta 6:209–215
28. Maier RM (2003) Biosurfactants: evolution and diversity. Adv
Appl Microbiol 52:101–121
29. Mireles JR, Toguchi A, Harshey RM (2001) Salmonella enterica
serovar typhimurium swarming mutants with altered biofilm-
forming abilities: surfactin inhibits biofilm formation. J Bacteriol
183:5848–5854
30. Mukherjee S, Das P, Sen R (2006) Towards commercial pro-
duction of microbial surfactants. Trends Biotechnol 24:509–515
31. Muthusamy K, Gopalakrishnan S, Ravi Tk, Sivachidambaram P
(2008) Biosurfactants: properties, commercial production and
application. Curr Microbiol 94:736–747
32. Nitschke M, Ferraz C, Pastore GM (2004) Selection of micro-
organisms for biosurfactant production using agroindustrial
wastes. Braz J Microbiol 35:336–341
33. Pratt-Terpstra IH, Busscher HJ (1989) Microbial factors in a
thermodynamic approach of oral streptococcal adhesion to solid
substrata. J Colloid Interface Sci 129:568–574
34. Rahman KSM, Gakpe E (2008) Production, characterization
and applications of biosurfactants—review. Biotechnology 7:
360–370
35. Rodrigues LR, Teixeira JA, Van Der Mei HC, Oliveira R (2006)
Isolation and partial characterization of a biosurfactant produced
by Streptococcus thermophilus A. Colloids Surf B Biointerfaces
53:105–112
36. Rodrigues LR, Teixeira JA, Van Der Mei HC, Oliveira R (2006)
Physicochemical and functional characterization of a biosurfac-
tant produced by Lactococcus lactis 53. Colloids Surf B Bioin-
terfaces 49:79–86
37. Rodrigues LR, Banat IM, Van Der Mei HC, Teixeira JA, Oliveira
R (2006) Interference in adhesion of bacteria and yeasts isolated
from explanted voice prostheses to silicone rubber by rhamnoli-
pid biosurfactants. J Appl Microbiol 100:470–480
38. Rodrigues LR, Moldes A, Teixeira JA, Oliveira R (2006) Kinetic
study of fermentative biosurfactant production by Lactobacillus
strains. Biochem Eng J 28:109–116
39. Rodrigues LR, Van Der Mei HC, Teixeira JA, Oliveira R (2004)
Biosurfactant from Lactococcus lactis 53 inhibit microbial adhe-
sion on silicone rubber. Appl Microbiol Biotechnol 66:306–311
40. Rodrigues LR, Van Der Mei HC, Teixeira JA, Oliveira R (2004b)
Influence of biosurfactants from probiotic bacteria on formation
of biofilms on voice prostheses
41. Rufino RD (2006) Produc¸a˜o de biossurfactante por Candida
lipolytica. Recife (2006) Dissertac¸a˜o (Mestrado em Micologia).
Centro de Cieˆncias Biolo´gicas, Universidade Federal de Per-
nambuco, 95f
42. Rufino RD, Sarubbo LA, Campos-Takaki GM (2008) Enhance-
ment of stability of biosurfactant produced by Candida lipolytica
using industrial residue as substrate. World J Microbiol Bio-
technol 23:729–734
43. Sarubbo LA, Farias CBB, Campos-Takaki GM (2007) Co-utili-
zation of canola oil and glucose on the production of a surfactant
by Candida lipolytica. Eletronic J Biotechnol 9:400–406
J. Luna et al.: Evaluation Antimicrobial and Antiadhesive Properties
123
44. Sarubbo LA, Luna JM, Campos-Takaki GM (2006) Production
and stability studies of the bioemulsifier obtained from a new
strain of Candida glabrata UCP1002. Eletronic J Biotechnol
9:400–406
45. Singh P, Cameotra S (2004) Potential applications of microbial
surfactants in biomedical sciences. Trends Biotechnol 22:142–146
46. Singh A, Van Hamme JD, Ward OP (2007) Surfactants in
microbiology and biotechnology: Part 2. Application aspects.
Biotechnol Adv 25:99–121
47. Sobrinho HBS, Rufino RD, Luna JM, Salgueiro AA, Campos-
Takaki GM, Leite LFC (2008) Utilization of two agroindustrial
by-products for the production of a surfactant by Candida spha-
erica UCP0995. Process Biochem 43:912–917
48. Velraeds-Martine MC, Vander Mei HC, Reid G, Busscher HJ
(1996) Physiochemical and biochemical characterization of bio-
surfactants released by Lactobacillus strains. Colloids Surf B
Biointerfaces 8:51–61
J. Luna et al.: Evaluation Antimicrobial and Antiadhesive Properties
123
